Cargando…
Novel Non-Congeneric Derivatives of the Choline Kinase Alpha Inhibitor ICL-CCIC-0019
Choline kinase alpha (CHKA) is a promising target for the development of cancer therapeutics. We have previously reported ICL-CCIC-0019, a potent CHKA inhibitor with high cellular activity but with some unfavorable pharmacological properties. In this work, we present an active analogue of ICL-CCIC-0...
Autores principales: | Wang, Ning, Brickute, Diana, Braga, Marta, Barnes, Chris, Lu, Haonan, Allott, Louis, Aboagye, Eric O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309005/ https://www.ncbi.nlm.nih.gov/pubmed/34371769 http://dx.doi.org/10.3390/pharmaceutics13071078 |
Ejemplares similares
-
The novel choline kinase inhibitor ICL-CCIC-0019 reprograms cellular metabolism and inhibits cancer cell growth
por: Trousil, Sebastian, et al.
Publicado: (2016) -
Consideration of Metabolite Efflux in Radiolabelled Choline Kinetics
por: Li, Yunqing, et al.
Publicado: (2021) -
Development of a fluorine-18 radiolabelled fluorescent chalcone: evaluated for detecting glycogen
por: Allott, Louis, et al.
Publicado: (2020) -
Design, synthesis, and evaluation of a novel PET imaging agent targeting lipofuscin in senescent cells
por: Brickute, Diana, et al.
Publicado: (2022) -
Radiolabelling an (18)F biologic via facile IEDDA “click” chemistry on the GE FASTLab™ platform
por: Allott, Louis, et al.
Publicado: (2021)